PROPUL Evidence LLP is pleased to announce a significant milestone in advancing global health research and evidence synthesis. The World Health Organization (WHO) has officially released its technical report titled “Key Ingested Per- and Polyfluoroalkyl Substances (PFAS) and Their Health Effects: Landscape Review.” Our expert team at PROPUL Evidence LLP [...]
We are proud to share that Dr. Yuvaraj Krishnamoorthy has been independently verified and ranked among the World’s Top 5% Scientists in the 2025 SciRank Global Registry. This recognition reflects his ongoing contributions to research and his commitment to advancing scientific excellence through evidence-based work. The certificate, issued by SciRank [...]
Dr. Yuvaraj Krishnamoorthy, CEO & Managing Partner of PROPUL Evidence LLP, is a Member of the Joanna Briggs Institute (JBI) Expert Reference Group (ERG) in Infectious Diseases/Infection Control. The JBI ERG unites global leaders to shape evidence-based practices, implementation science, and policies for infection prevention and control worldwide. This role [...]
Dr. Yuvaraj Krishnamoorthy, CEO & Managing Partner of PROPUL Evidence LLP, serves as an Expert Member for the Evaluation of Proposals in the Joint Transnational Call – Transforming Health and Care Systems (JTC-THCS) 2026. This Horizon Europe Cofund initiative focuses on “Access to Care,” promoting equitable health services that address [...]
PROPUL Evidence LLP is proud to have contributed, in collaboration with experts from MGMCRI and JIPMER, to the Evidence-Based Guidelines on Lung Cancer Treatment and Palliation released by the Ministry of Health & Family Welfare, Government of India, ahead of World Cancer Day. The guidelines were formally released by the [...]